Sunshine Biopharma

NASDAQ: SBFM
Nasdaq Stock Market
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#47518
Country Rank
#5735
Market Cap
2.91 M
Price
1.8
Change (%)
1.64%
Volume
38,262

Sunshine Biopharma (NASDAQ: SBFM) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
06/01/2026 1:10 x0.1 x0.000000000625 Reverse
08/08/2024 1:20 x0.05 x0.00000000625 Reverse
04/17/2024 1:100 x0.010 x0.000000125 Reverse
02/09/2022 1:200 x0.005 x0.0000125 Reverse
04/06/2020 1:20 x0.05 x0.0025 Reverse
02/01/2019 1:20 x0.05 x0.05 Reverse

Frequently Asked Questions

  • How much would Sunshine Biopharma stock be worth if it never split?
    If Sunshine Biopharma (stock symbol: NASDAQ: SBFM) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-10) that occurred on 06/01/2026.
  • Sunshine Biopharma (stock symbol: NASDAQ: SBFM) has undergone a total of six stock splits. The most recent split occurred on 06/01/2026. One share bought prior to the first split on 02/01/2019 would now equal 0.00 shares.
  • Sunshine Biopharma (stock symbol: NASDAQ: SBFM) has undergone six stock splits in its history. The most recent split, a 1-for-20 split, occurred on 06/01/2026. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.